WO2025172894 - MODIFIED NANOPARTICLE SUBUNITS AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/172894
Publication Date
21.08.2025
International Application No.
PCT/IB2025/051559
International Filing Date
13.02.2025
Title **
[English]
MODIFIED NANOPARTICLE SUBUNITS AND USE THEREOF
[French]
SOUS-UNITÉS DE NANOPARTICULES MODIFIÉES ET LEUR UTILISATION
Applicants **
GLAXOSMITHKLINE BIOLOGICALS SA
Inventors
CAPPELLI, Luigia
COZZI, Roberta
WAHOME, Newton Muchugu
Priority Data
63/554,486
16.02.2024
US
63/689,019
30.08.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2672 | |
| EPO | Filing, Examination, Granting | 11805 | |
| Japan | Filing, Examination, Granting | 2294 | |
| South Korea | Filing, Examination, Granting | 2248 | |
| USA | Filing, Examination, Granting | 8340 |
Total:
27,359
Contact Us
Abstract[English]
The present invention relates to the field of modified nanoparticle subunits, immunogenic compositions and vaccines comprising the modified nanoparticles, their manufacture and the use of such compositions in medicine.[French]
La présente invention concerne le domaine des sous-unités de nanoparticules modifiées, des compositions immunogènes et des vaccins comprenant les nanoparticules modifiées, leur fabrication et l'utilisation de telles compositions en médecine.